SAGE Sage Therapeutics
- 14.510
- +0.820+5.99%
Sage Therapeutics News
Sage Therapeutics | 10-Q: Quarterly report
Sage Therapeutics | 8-K: Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics | ARS: Annual Report to Security Holders
Sage Therapeutics | DEFA14A: Others
Sage Therapeutics | DEF 14A: Definitive information statements
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Sage Therapeutics | 8-K: Current report
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Greene Barry E
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cook Anne Marie
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gault Laura
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer IGUCHI KIMI
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Benecchi Christopher
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sage Therapeutics | 10-K: Annual report
Sage Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(8.7%),Roderick Wong, M.D.(8.7%)
Sage Therapeutics | 8-K: Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Analysis
Price Target
No Data
